Titan Pharmaceuticals (TTNP)

TTNP was delisted on the 1st of October, 2025.

• Market cap: $6.13M
• Sector: Healthcare
• Industry: Biotechnology

About: Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.

Employees: 4